Chinese Journal of General Surgery ›› 2021, Vol. 30 ›› Issue (3): 269-275.doi: 10.7659/j.issn.1005-6947.2021.03.004

Previous Articles     Next Articles

Expression of NIMA-related kinase 2 in pancreatic cancer and its clinical significance

LIU Xiangmei, XU Dafeng, WANG Chunling, FU Yuzheng, WANG Dan, WU Jincai   

  1. (Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University,  Haikou, 570000, China)
  • Received:2021-01-10 Revised:2021-02-28 Online:2021-03-25 Published:2021-04-06

Abstract: Background and Aims: The expression of NIMA-related kinase 2 (NEK2) is increased in a variety of malignant tumors, and is closely associated with tumor progression and patients’ unfavorable prognosis. However, the expression of NEK2 and its significance in pancreatic cancer are still unclear. Therefore, this study was conducted to investigate the NEK2 expression in pancreatic cancer tissue and its relationship with clinicopathologic factors and prognosis of the patients.  
Methods: The surgical specimens from 108 patients with pancreatic cancer undergoing pancreatectomy from January 2013 to December 2014 in the Department of Hepatopancreatobiliary Surgery of Hainan Provincial People's Hospital as well as the clinicopathologic and follow-up data of these patients were collected. The expressions of NEK2 in the tissue samples were detected by immunohistochemical staining. The relations of NEK2 with the clinicopathologic factors were analyzed, and the difference in tumor-free survival and overall survival rates between patients with different NEK2 expression levels were analyzed and compared by Kaplan-Meier survival curve and Log-rank analysis. The prognostic factors were determined by Cox proportional hazard model.
Results: There was no NEK2 expression in the normal pancreatic tissue, while in the 108 samples of pancreatic cancer tissue, high and low NEK2 expressions were found in 63 cases (58.3%) and 45 cases (41.7%), respectively. The NEK2 expression was significantly associated with CA19-9 level (P=0.015), TNM stage (P=0.002), tumor differentiation (P=0.034), and lymph node metastasis (P=0.043), but irrelevant to sex, age, smoking, CEA level, tumor size and tumor location (all P>0.05). The 1-, 3- and 5-year disease-free survival rates were 60.5%, 20.7% and 5.2% in patients with high NEK2 expression, and 75.4%, 50.6% and 24.9% in patients with low NEK2 expression, and the 1-, 3- and 5-year overall survival rates were 75.6%, 42.2% and 15.3% in patients with NEK2 expression, and 85.7%, 60.6% and 30.1% in patients with low NEK2 expression, respectively. Both disease-free survival and overall survival rates in patients with high NEK2 expression were significantly lower than those in patients with low NEK2 expression (both P<0.05). Univariate and multivariate analysis showed that TNM stage (P=0.029), lymph node metastasis (P=0.016) and NEK2 high expression (P=0.032) were independent influencing factors for tumor-free survival, and TNM stage (P=0.035), degree of differentiation (P=0.042), lymph node metastasis (P=0.006) and NEK2 high expression (P=0.000) were independent influencing factors for overall survival. 
Conclusion: High NEK2 expression is an independent risk factor for the prognosis of pancreatic carcinoma patients, and NEK2 can be used as an indicator for prognosis of pancreatic carcinoma patients after operation.

Key words: Pancreatic Neoplasms, NIMA-Related Kinase2, Prognosis

CLC Number: 

  • R735.9 
[1] HAN Shifeng, JIN Chunfeng, ZHU Lei. Clinical value of prognostic index in postoperative evaluation of patients with resectable pancreatic ductal adenocarcinoma [J]. Chinese Journal of General Surgery, 2021, 30(3): 247-253.
[2] QIN Wen, CHEN Taiwen, ZHENG Haiping, YANG Jianyu, ZHU Xiaodong . Association of serum ANGPTL2 with clinicopathologic features of pancreatic cancer and its diagnostic value for pancreatic cancer [J]. Chinese Journal of General Surgery, 2021, 30(3): 254-260.
[3] LI Mingxu, ZHONG Chengcheng, ZHANG Gongming, HU Wei, , WANG Zhong, . Expression of DEP domain protein 1B in pancreatic cancer and its clinical significance [J]. Chinese Journal of General Surgery, 2021, 30(3): 261-268.
[4] ZHANG Bo, XU Tao, XU Hao, XIA Yu, ZHOU Wence, . Identification of hub genes in pancreatic adenocarcinoma and construction of a support vector machine diagnostic classifier based on bioinformatics approaches [J]. Chinese Journal of General Surgery, 2021, 30(3): 276-285..
[5] LI Weiwei, LIU Jinlong . Advances in clinical application of circulating tumor DNA in pancreatic cancer [J]. Chinese Journal of General Surgery, 2021, 30(3): 337-342.
[6] XIE Xuewen, FEI Shuke. Research progress of the role of neutrophil extracellular traps in pancreatic diseases [J]. Chinese Journal of General Surgery, 2021, 30(3): 343-348.
[7] WANG Puxiongzhi, YU Xinzhe, SHI Xiangjun, YUAN Zhou. Research progress in immunotherapy for pancreatic ductal adenocarcinoma [J]. Chinese Journal of General Surgery, 2021, 30(3): 330-336.
[8] LIU Jisheng, , LIU He, LIU Hao, YU Xing, LI Hao. Expression of TIP30 in intrahepatic cholangiocarcinoma and its significance [J]. Chinese Journal of General Surgery, 2021, 30(2): 187-194.
[9] ZHANG Fan, LI Zedong, PENG Yu, CHEN Sheng, ZHOU Jun. Construction of decision tree for diagnosis of pancreatic cancer based on serum miRNA expression data [J]. Chinese Journal of General Surgery, 2021, 30(2): 211-218.
[10] LI Liuzheng, WANG Junfeng, XU Leisheng, AO Qiang, GAO Xuechang, GONG Guocha, SHEN Weiwen, WANG Xue, FENG Jiawei. Surgical treatment of hilar cholangiocarcinoma: a report of 44 cases [J]. Chinese Journal of General Surgery, 2021, 30(2): 140-150.
[11] WEI Yongjian, REN Longfei, ZHANG Lei, LI Xun. Prognostic value of preoperative platelet to lymphocyte ratio in patients with hepatocellular carcinoma undergoing hepatectomy: a Meta-analysis [J]. Chinese Journal of General Surgery, 2021, 30(1): 44-54.
[12] LI Jun, LI Li, LI Yonggan, ZHAO Yanbing, ZHANG Wei, SU Yuheng, ZHANG Jie, LI Shipeng. Relations of serum lncRNA HULC level with the clinical features and prognosis of patients with hepatitis B virus-related hepatocellular carcinoma [J]. Chinese Journal of General Surgery, 2021, 30(1): 64-70.
[13] ZHOU Faquan, , CHEN Shi, SUN Hongyu, TANG Lijun. Prognostic value of the systemic immune-inflammation index in patients with pancreatic cancer: a systematic review and Meta-analysis [J]. Chinese Journal of General Surgery, 2020, 29(9): 1076-1083.
[14] CAO Lijun, ZHANG Pinjie, HU Qiuyuan, CHEN Hu, SUN Yun. Emphysematous pancreatitis: a report of three cases and literature review  [J]. Chinese Journal of General Surgery, 2020, 29(9): 1098-1104.
[15] HUANG Zhiwei, TAN Peng, , DU Yichao, , SHI Hao, CHEN Hao, QIAN Baolin, LIU Yu, FU Wenguang, , LI Qiu. Influence of cryptotanshinone on biological behaviors of pancreatic cancer cells and the action mechanism [J]. Chinese Journal of General Surgery, 2020, 29(9): 1060-1068.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Chinese Journal of General Surgery, 2020, 29(4): 510 -514 .
[2] . [J]. Chinese Journal of General Surgery, 2020, 29(5): 630 -634 .
[3] XIAO Weixing, ZHOU Jun, GU Mengjia, XIAO Guangyuan. Application of precise hepatectomy techniques in treatment of intrahepatic stones[J]. Chinese Journal of General Surgery, 2016, 25(2): 191 -196 .
[4] . [J]. Chinese Journal of General Surgery, 2020, 29(4): 498 -503 .
[5] BAI Ning1, 2, WANG Dong2, OUYANG Xiwu2, ZHOU Ledu2, WANG Zhiming2. Inhibitory effect of matrine against hepatic ischemia-reperfusion injury in rats and its mechanism[J]. , 2018, 27(1): 81 -86 .
[6] . [J]. Chinese Journal of General Surgery, 2020, 29(4): 504 -509 .
[7] HUANG Juan, HU Yuanping, CHEN Chuang, QI Xiaowei. Some considerations regarding clinical problems in breast cancer treatment during the special period of novel coronavirus pneumonia outbreak[J]. Chinese Journal of General Surgery, 2020, 29(2): 153 -160 .
[8] LIAO Xinfang1, LI Zhengrong2, YANG Qingshui1, ZHANG Xiangcheng2, LI Zhu1, JIE Zhigang2. Role of microRNA-139-5p and its target gene Notch1 in colorectal cancer[J]. Chinese Journal of General Surgery, 0, (): 1373 -1378 .
[9] XIANG Canhong, TONG Xuan. Surgical treatment of hilar cholangiocarcinoma: progress and controversy[J]. , 2018, 27(2): 137 -142 .
[10] HUANG Gengwen, SHEN Dingcheng, HE Wen, YANG Liu, ZHOU Shuyi, YANG Jianyi, JI Lia. Laparoscopic inguinal hernia repair with enhanced recovery after surgery protocols[J]. , 2016, 25(10): 1470 -1474 .